Widecells Group competitors

Widecells Group's competitors include Cord Blood America, Clementia Pharmaceuticals, Synthace and International Stem Cell Corporation
Add company...
Widecells Group
WideCells Group is a worldwide provider of stem cell services.
Cord Blood America
Cord Blood America, Inc. provides cord blood and cord tissue stem cell services.
Clementia Pharmaceuticals
Clementia Pharmaceuticals develops and commercializes therapeutics for people suffering from rare diseases.
Synthace
Synthace produces bio-based chemical products through the application of synthetic biology.
International Stem Cell Corporation
International Stem Cell Corporation is a California-based biotechnology company focused on therapeutic and research products.
Founding Date
Founding Date
2012
Founding Date
1999
Founding Date
2012
Founding Date
2011
Founding Date
2001
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Manchester, GB HQ
Locations
Las Vegas, US HQ
Locations
Westmount, CA HQ
Newton, US
Locations
London, GB HQ
Locations
Carlsbad, US HQ
Employees
Employees
8
Employees
15
Employees
422% increase
Employees
425% increase
Employees
41
Valuation ($)
Valuation ($)
9.7 m
Valuation ($)
3.7 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
6.7 m
Facebook likes
Facebook likes
4 k
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
66
Facebook likes
3.8 k
Twitter followers
Twitter followers
285
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
506
Twitter followers
10.1 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$3.3m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
£581 (FY, 2013)
Revenue (est.)
$7.2b (FY, 2016)
Cost of goods
Cost of goods
N/A
Cost of goods
$904.9k (FY, 2016)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$1.9b (FY, 2016)
Gross profit
Gross profit
N/A
Gross profit
$2.4m (FY, 2016)
Gross profit
N/A
Gross profit
N/A
Gross profit
$5.2b (FY, 2016)
Net income
Net income
N/A
Net income
$102.2k (FY, 2016)
Net income
($57.5m) (FY, 2016)
Net income
(£361.6k) (FY, 2013)
Net income
($1.1b) (FY, 2016)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 60m (almost 3 years ago)
Latest funding round
$ 9.9m (9 months ago)
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 92.5m
Total funding raised
$ 16.2m
Total funding raised
$ 2.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Cord Blood America
HQ
Las Vegas, US
Employees
15

Cord Blood America, Inc. provides cord blood and cord tissue stem cell services.

View company
Clementia Pharmaceuticals
HQ
Westmount, CA
Employees
42↑ 2% increase

Clementia Pharmaceuticals develops and commercializes therapeutics for people suffering from rare diseases.

View company
Synthace
HQ
London, GB
Employees
42↑ 5% increase

Synthace produces bio-based chemical products through the application of synthetic biology.

View company
International Stem Cell Corporation
HQ
Carlsbad, US
Employees
41

International Stem Cell Corporation is a California-based biotechnology company focused on therapeutic and research products.

View company